Thursday, December 4, 2008 - 9:44PM EST

Drug Therapy

1. Meta-analysis of the cholesterol-lowering effect of ezetimibe added to ongoing statin therapy.

Author
Mikhailidis DP; Sibbring GC; Ballantyne CM; Davies GM; Catapano AL;
Institution
Department of Clinical Biochemistry (Vascular Disease Prevention Clinics), Royal Free Hospital, Royal Free and University College School of Medicine, London, UK. MIKHAILIDIS@aol.com <MIKHAILIDIS@aol.com>
Journal
Curr Med Res Opin. 2007 Aug;23(8):2009-26.
Abstract URL
Click here to view abstract

2. Effects of once weekly rosuvastatin among patients with a prior statin intolerance.

Author
Backes JM; Moriarty PM; Ruisinger JF; Gibson CA;
Institution
Department of Pharmacy Practice, Kansas University Medical Center, Kansas City, Kansas, USA.
Journal
Am J Cardiol. 2007 Aug 1;100(3):554-5. Epub 2007 Jun 18.
Abstract URL
Click here to view abstract

3. Non-cardiovascular mortality, low-density lipoprotein cholesterol and statins: a meta-regression analysis.

Author
Razzolini R; Tarantini G; Ossena G; Favaretto E; Bilato C; Manzato E; Dalla-Volta S; Iliceto S;
Institution
Department of Cardiology, University of Padova Medical School, Padova, Italy. renato.razzolini@unipd.it
Journal
Cardiology. 2008;109(2):110-6. Epub 2007 Aug 16.
Abstract URL
Click here to view abstract

4. Treatment of hypercholesterolemia with ezetimibe in cardiac transplant recipients.

Author
Patel AR; Ambrose MS; Duffy GA; Cote H; DeNofrio D;
Institution
Heart Failure and Cardiac Transplant Center, Tufts-New England Medical Center, Boston, Massachusetts 02111, USA. apatel@tufts-nemc.org
Journal
J Heart Lung Transplant. 2007 Mar;26(3):281-4.
Abstract URL
Click here to view abstract

5. One-month therapy with simvastatin restores endothelial function in hypercholesterolemic children and adolescents.

Author
Ferreira WP; Bertolami MC; Santos SN; Barros MR; de Matos Barretto RB; Pontes SC Jr; Fonseca FH; Carvalho AC;
Institution
Instituto Dante Pazzanese de Cardiologia, Av. Dr. Dante Pazzanese, 500 Bairro Ibirapuera, 04012-180 Sao Paulo, Brazil. wferreir@uol.com.br
Journal
Pediatr Cardiol. 2007 Jan-Feb;28(1):8-13. Epub 2007 Jan 25.
Abstract URL
Click here to view abstract

6. Incremental benefit and cost-effectiveness of high-dose statin therapy in high-risk patients with coronary artery disease.

Author
Chan PS; Nallamothu BK; Gurm HS; Hayward RA; Vijan S;
Institution
University of Michigan Department of Internal Medicine, Ann Arbor, MI, USA. paulchan@umich.edu
Journal
Circulation. 2007 May 8;115(18):2398-409. Epub 2007 Apr 23.
Abstract URL
Click here to view abstract

7. Statins and cancer risk.

Author
Karp I; Behlouli H; Lelorier J; Pilote L;
Institution
Department of Social and Preventive Medicine, University of Montreal, Quebec, Canada.
Journal
Am J Med. 2008 Apr;121(4):302-9.
Abstract URL
Click here to view abstract

8. Ezetimibe for the treatment of primary (heterozygous-familial and non-familial) hypercholesterolaemia: NICE technology appraisal guidance.

Author
Charles Z; Pugh E; Barnett D;
Institution
National Institute for Health and Clinical Excellence, UK.
Journal
Heart. 2008 May;94(5):642-3.

9. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis.

Author
Kearney PM; Blackwell L; Collins R; Keech A; Simes J; Peto R; Armitage J; Baigent C; Kearney PM; Blackwell L; Collins R; Keech A; Simes J; Peto R; Armitage J; Baigent C; Kearney PM; Blackwell L; Collins R; Keech A; Simes J; Peto R; Armitage J; Baigent C;
Institution
Journal
Lancet. 2008 Jan 12;371(9607):117-25.
Abstract URL
Click here to view abstract

10. High-dose statin therapy for secondary prevention of stroke: stroke prevention by aggressive reduction in cholesterol levels study review.

Author
Schwertz DW; Badellino KO;
Institution
College of Nursing, University of Illinois at Chicago, IL 60612, USA. schwertz@uic.edu
Journal
J Cardiovasc Nurs. 2008 Jan-Feb;23(1):8-13.
Abstract URL
Click here to view abstract
Pages: 1 2